Form 4: Disc Medicine Director Acquires Stock Options

William Richard White, a director of Disc Medicine, Inc., acquired stock options for 10,000 shares on June 12, 2024.

Summary

• William Richard White, a director at Disc Medicine, Inc. (IRON), filed a Form 4 on June 14, 2024.
• The filing reports a transaction that occurred on June 12, 2024, where White acquired stock options for 10,000 shares of Disc Medicine's common stock.
• The exercise price of the stock options is $38.85.
• The options vest upon the earlier of the company's 2025 annual meeting or the one-year anniversary of the grant date, contingent on White's continued service.
• Following the reported transaction, White beneficially owns 10,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director, suggesting confidence but not necessarily a major positive or negative event.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the options is contingent on the earlier of the company's 2025 annual meeting or the one-year anniversary of the grant date, subject to the Reporting Person's continued service.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment, as it may signal confidence in the company's future prospects.

Key Dates